Last reviewed · How we verify
Polyethylene glycol + ascorbate — Competitive Intelligence Brief
marketed
Osmotic laxative bowel preparation agent
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
Polyethylene glycol + ascorbate (Polyethylene glycol + ascorbate) — Parc de Salut Mar. Polyethylene glycol with ascorbate acts as an osmotic laxative that draws water into the intestinal lumen while ascorbate enhances bowel cleansing efficacy.
Comparator set (2 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Polyethylene glycol + ascorbate TARGET | Polyethylene glycol + ascorbate | Parc de Salut Mar | marketed | Osmotic laxative bowel preparation agent | ||
| Miralax-Gatorade Prep | Miralax-Gatorade Prep | VA Office of Research and Development | marketed | Osmotic laxative bowel preparation agent | ||
| Moviprep(1-day treatment) | Moviprep(1-day treatment) | Nihon Pharmaceutical Co., Ltd | phase 3 | Osmotic laxative bowel preparation agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Osmotic laxative bowel preparation agent class)
- Nihon Pharmaceutical Co., Ltd · 1 drug in this class
- Parc de Salut Mar · 1 drug in this class
- VA Office of Research and Development · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Polyethylene glycol + ascorbate CI watch — RSS
- Polyethylene glycol + ascorbate CI watch — Atom
- Polyethylene glycol + ascorbate CI watch — JSON
- Polyethylene glycol + ascorbate alone — RSS
- Whole Osmotic laxative bowel preparation agent class — RSS
Cite this brief
Drug Landscape (2026). Polyethylene glycol + ascorbate — Competitive Intelligence Brief. https://druglandscape.com/ci/polyethylene-glycol-ascorbate. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab